This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists.
The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.
https://andro.io/app/diabetescares
Power 100
Android app profile
SGLT2 & GLP-1 in Diabetes for Android – Latest Version & Features
★★★★★
(0 ratings)
Rate this app
How do you feel about SGLT2 & GLP-1 in Diabetes?
Thanks for your feedback!
> 2.2k
Monthly Downloads
~$900
Estimated Cost
Screenshots
